Article
The role of telomerase reverse transcriptase (TERT) promoter mutations in prognosis in bladder cancer.
Bioengineered - 1 Dec 2021
Wan Song, Liu Xuan, Hua Wei, Xi Ming, Zhou Yulin, Wan Yueping
Abstract excerpt
Telomerase reverse transcriptase (TERT) promoter mutations have been recognized as a common genetic event in bladder cancer (BC). Many studies have found the high TERT promoter mutations' prevalence in BC recurrence patients which may make the TERT promoter mutations become a potential prognosis prediction of BC. We performed a systematic search in Embase, PubMed, and Web of Science in January 2021. The aspects...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
